Furthermore, in a follow up flow cytometry experiment we found that the frequency of F4/80+ cells expressing Arg1+, a marker associated with tumor-associated M2-like macrophage population, was also decreased by Vactosertib treatment (Figure 7G). This evidence concerns the gene ARG1 and neoplasm.